refar12 vs hotexib
Head-to-head comparison across 9 metrics. Score: 0 — 7.
🔄 More Comparisons
Compare refar12 with:
Compare hotexib with:
refar12 vs hotexib — Who Comes Out on Top?
In this head-to-head comparison, refar12 leads in 0 out of 9 metrics, while hotexib leads in 7 (2 tied).
In terms of followers, hotexib has the edge with a 2.6K follower advantage. hotexib holds the peak viewer record at 39 concurrent viewers.
When it comes to streaming consistency, hotexib puts in more hours averaging 1.8h per day compared to 0.3h.
This comparison is based on data collected by NovaCamX every 15 minutes, providing accurate real-time and historical statistics that you won't find on other platforms.